Completed
Post-marketing Study to Evaluate the Effect of Mirabegron on the Plasma Concentration of Tolterodine
NCT01964183
- Conditions
- Healthy, Pharmacokinetics of Mirabegron and Tolterodine
- Locations
-
- Kanto, Japan